NEW YORK (360Dx) – Ceres Nanosciences said today that with Tasso, George Mason University, and the United States Army Medical Research Institute of Infectious Diseases, it has received $4.25 million from the US Department of Defense's Defense Threat Reduction Agency (DTRA) to develop a platform for surveillance of infectious disease outbreaks.

The award is part of a larger, multi-year $11.7 million program funded by the DTRA through which Ceres will work to integrate its Nanotrap enrichment technology with Tasso's HemoLink blood sampling device.